Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norspan versus placebo in chronic osteoarthritis pain
2004-000414-39Phase 4Completed
- Sponsor
- Mundipharma
- Start
- Jun 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of buprenorphine in osteoarthritis (OA) (2 arms), sponsored by Mundipharma. Primary endpoint: Change in WOMAC OA Index pain score. Started Jun 2004; status: completed.
02
Drugs
buprenorphine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2004-000414-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000414-39.